Successful treatment of refractory Sneddon-Wilkinson disease (subcorneal pustular dermatosis) with infliximab

Dermatol Ther. 2022 Jul;35(7):e15552. doi: 10.1111/dth.15552. Epub 2022 May 13.

Authors

Maurizio Romagnuolo^{1

2}, Simona Muratori¹, Angelo Cattaneo¹, Angelo Valerio Marzano^{1

2}, Chiara Moltrasio^{2

3}

Affiliations

¹ Dermatology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
² Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
³ Department of Medical Surgical and Health Sciences, University of Trieste, Trieste, Italy.

No abstract available

Publication types

Letter

MeSH terms

Humans
Infliximab / therapeutic use
Skin Diseases, Vesiculobullous* / diagnosis
Skin Diseases, Vesiculobullous* / drug therapy

Substances

Infliximab